United States · FDA National Drug Code directory

Naproxen

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
25000-139_e5013319-e2f4-4cd0-9523-1ffd352fe2d9
Product NDC
25000-139
Form
TABLET
Composition / generic term
Naproxen
Labeler
MARKSANS PHARMA LIMITED
Marketing category
ANDA
Marketing start / end (source format)
20110228
Source listing expiry
20261231

Source-listed ingredients

  • NAPROXEN — 375 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE (25000-139-03) · 25000-139-03
  • 1000 TABLET in 1 BOTTLE (25000-139-14) · 25000-139-14
  • 4 BAG in 1 BOX (25000-139-22) / 4500 TABLET in 1 BAG · 25000-139-22
  • 6 BAG in 1 BOX (25000-139-32) / 4500 TABLET in 1 BAG · 25000-139-32
  • 1 BAG in 1 BOX (25000-139-98) / 25300 TABLET in 1 BAG · 25000-139-98

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →